Bharat Immunological & Biological Corporation Ltd Financials
Bharat Immunological & Biological Corporation Ltd Financial Statement
*All values are in Rs. Cr
| Particulars | Sep 2023 | Jun 2023 | Mar 2023 |
|---|---|---|---|
| Revenue | 0.16 | 0.10 | 8.15 |
| Operating Expense | 4.69 | 4.31 | 11.67 |
| Net Profit | -4.92 | -4.59 | -3.88 |
| Net Profit Margin | -3,075 | -4,590 | -47.61 |
| Earning Per Share | -1.14 | -1.06 | -0.90 |
| EBIDTA | -2.80 | -2.84 | -1.73 |
| Effective Tax Rate | TBA | TBA | TBA |
| Particulars | Sep 2023 |
|---|---|
| Revenue | 0.16 |
| Operating Expense | 4.69 |
| Net Profit | -4.92 |
| Net Profit Margin | -3075.00 |
| Earning Per Share | -1.14 |
| EBIDTA | -2.80 |
| Effective Tax Rate | TBA |
Invest in Bharat Immunological & Biological Corporation Ltd
₹0 Brokerage*
Open Demat Account
*By signing up you agree to our Terms and Conditions
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Total Revenue Annual | 44.61 | 78.39 | 85.33 |
| Operating Expenses Annual | 63.08 | 83.37 | 106.21 |
| Operating Profit Annual | -15.66 | -3.88 | -19.19 |
| Interest Annual | 7.04 | 5.59 | 4.78 |
| Depreciation | 0.15 | 0.21 | 0.24 |
| Net Profit Annual | -17.06 | -8.75 | -18.11 |
| Tax Annual | -5.79 | -0.93 | -6.10 |
| Particulars | Mar 2023 |
|---|---|
| Total Revenue Annual | 44.61 |
| Operating Expenses Annual | 63.08 |
| Operating Profit Annual | -15.66 |
| Interest Annual | 7.04 |
| Depreciation | 0.15 |
| Net Profit Annual | -17.06 |
| Tax Annual | -5.79 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Cash Flow at the Beginning | 4.64 | 1.23 | 0.99 |
| Cash Flow from Operations | 10.89 | -42.12 | 11.78 |
| Cash Flow from Investing | 0.46 | 0.53 | 0.67 |
| Cash Flow from Financing | -14.71 | 45 | -12.20 |
| Cash Flow at the End | 1.29 | 4.64 | 1.23 |
| Particulars | Mar 2023 |
|---|---|
| Cash Flow at the Beginning | 4.64 |
| Cash Flow from Operations | 10.89 |
| Cash Flow from Investing | 0.46 |
| Cash Flow from Financing | -14.71 |
| Cash Flow at the End | 1.29 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| PBDIT Margin (%) | -35.10 | -4.94 | -22.48 |
| PBIT Margin (%) | -35.44 | -5.20 | -22.76 |
| PBT Margin (%) | -30.42 | -4.27 | -18.01 |
| Net PROFIT Margin (%) | -38.24 | -11.16 | -21.22 |
| Return On Networth / Equity (%) | TBA | TBA | TBA |
| Return On Networth /Employed (%) | TBA | TBA | TBA |
| Return On Assets (%) | -9.56 | -6.81 | -37.57 |
| Total Debt / Equity (X) | TBA | TBA | 1.33 |
| Asset Turnover Ratio (%) | 0.25 | 0.61 | 1.77 |
| Particulars | Mar 2023 |
|---|---|
| PBDIT Margin (%) | -35.10 |
| PBIT Margin (%) | -35.44 |
| PBT Margin (%) | -30.42 |
| Net PROFIT Margin (%) | -38.24 |
| Return On Networth / Equity (%) | TBA |
| Return On Networth /Employed (%) | TBA |
| Return On Assets (%) | -9.56 |
| Total Debt / Equity (X) | TBA |
| Asset Turnover Ratio (%) | 0.25 |
*All values are in Rs. Cr
Standalone
Consolidated
| Particulars | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|
| Fixed Assets Annual | 115.33 | 115.98 | 4.23 |
| Total Current Assets Annual | 33.06 | 65.43 | 33.95 |
| Non Current Assets Annual | 152.60 | 147.30 | 70.03 |
| Total Shareholders Funds Annual | 87.80 | 105.35 | 34.04 |
| Total Assets Annual | 185.66 | 212.73 | 103.99 |
| Particulars | Mar 2023 |
|---|---|
| Fixed Assets Annual | 115.33 |
| Total Current Assets Annual | 33.06 |
| Non Current Assets Annual | 152.60 |
| Total Shareholders Funds Annual | 87.80 |
| Total Assets Annual | 185.66 |
No Data Availabe
